335 related articles for article (PubMed ID: 10527951)
1. A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90.
Itoh H; Ogura M; Komatsuda A; Wakui H; Miura AB; Tashima Y
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):697-703. PubMed ID: 10527951
[TBL] [Abstract][Full Text] [Related]
2. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
Thulasiraman V; Matts RL
Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.
Okada M; Itoh H; Hatakeyama T; Tokumitsu H; Kobayashi R
Biochem J; 2003 Sep; 374(Pt 2):433-41. PubMed ID: 12803546
[TBL] [Abstract][Full Text] [Related]
4. An unstructured C-terminal region of the Hsp90 co-chaperone p23 is important for its chaperone function.
Weikl T; Abelmann K; Buchner J
J Mol Biol; 1999 Oct; 293(3):685-91. PubMed ID: 10543959
[TBL] [Abstract][Full Text] [Related]
5. The Ah receptor is a sensitive target of geldanamycin-induced protein turnover.
Chen HS; Singh SS; Perdew GH
Arch Biochem Biophys; 1997 Dec; 348(1):190-8. PubMed ID: 9390191
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
8. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin differently affects amino terminal and carboxyl terminal domains of HSP90.
Ishida R; Takaoka Y; Yamamoto S; Miyazaki T; Otaka M; Watanabe S; Komatsuda A; Wakui H; Sawada K; Kubota H; Itoh H
FEBS Lett; 2008 Nov; 582(28):3879-83. PubMed ID: 18955054
[TBL] [Abstract][Full Text] [Related]
10. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W; Yuan X; Xiang Z; Mimnaugh E; Marcu M; Neckers L
Nat Struct Mol Biol; 2005 Feb; 12(2):120-6. PubMed ID: 15643424
[TBL] [Abstract][Full Text] [Related]
11. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system.
Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM
EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476
[TBL] [Abstract][Full Text] [Related]
12. Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin.
Lee YS; Marcu MG; Neckers L
Chem Biol; 2004 Jul; 11(7):991-8. PubMed ID: 15271357
[TBL] [Abstract][Full Text] [Related]
13. The charged region of Hsp90 modulates the function of the N-terminal domain.
Scheibel T; Siegmund HI; Jaenicke R; Ganz P; Lilie H; Buchner J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1297-302. PubMed ID: 9990018
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
15. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.
Wang X; Heuvelman DM; Carroll JA; Dufield DR; Masferrer JL
Cancer Invest; 2010 Jul; 28(6):635-41. PubMed ID: 20394503
[TBL] [Abstract][Full Text] [Related]
16. A Nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket.
Söti C; Rácz A; Csermely P
J Biol Chem; 2002 Mar; 277(9):7066-75. PubMed ID: 11751878
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin, a heat shock protein 90-binding agent, disrupts Stat5 activation in IL-2-stimulated cells.
Xu W; Yu F; Yan M; Lu L; Zou W; Sun L; Zheng Z; Liu X
J Cell Physiol; 2004 Feb; 198(2):188-96. PubMed ID: 14603521
[TBL] [Abstract][Full Text] [Related]
18. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ
Nature; 2003 Sep; 425(6956):407-10. PubMed ID: 14508491
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Hsf1 activity by novobiocin and geldanamycin.
Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
[TBL] [Abstract][Full Text] [Related]
20. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates.
Hartson SD; Thulasiraman V; Huang W; Whitesell L; Matts RL
Biochemistry; 1999 Mar; 38(12):3837-49. PubMed ID: 10090774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
